-
Mashup Score: 0
I was once intensely skeptical that telehealth could offer good medicine. I was wrong.
Source: www.nytimes.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Vascular biomarkers reveal a unique toxicity profile of posttransplant cyclophosphamide: secondary analysis of BMT CTN 0402 and 1202 - 1 month(s) ago
Key PointsPTCy uniquely alters vascular biomarkers, with an increase in Ang-2 and a decrease in EGF at day +28 after transplant.Tac/Sir regimen also alters
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
@ASamerAlHomsi1 @MGooptu @hamiltkyb #PTCy increases Ang2 and decreases EGF. Possible relationship to toxicity profile? https://t.co/cNBSmnWY4Z
-
-
Mashup Score: 49
Program: Oral and Poster Abstracts Type: Oral Session: 722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Avoiding GVHD and Improving Outcomes Hematology Disease Topics & Pathways: Research, Clinical trials, Elderly, Clinical Research, Treatment Considerations, Study Population, Human Sameem Abedin, MD 1, Qinghua Lian 2 *, Michael J Martens, PhD 3 *, MHD Monzr M. Al Malki, MD 4, Hany Elmariah, MD, MS 5, Mahasweta Gooptu, MD 6, Karilyn T. Larkin, MD 7, Brian C. Shaffer, MD,
Source: ash.confex.comCategories: General Medicine News, Hem/OncsTweet-
🚨Breaking News/Good News from #ASH24🚨 >90% 1-year OS in PTCy-treated alloHCT recipients age 70+ enrolled in @BMTCTN 1703! 😱 Important analysis by @sameem_abedin @MediHumdani @GvHD_Meade and team!! 🙌 https://t.co/afM75mk4nk #PTCyrules
-
-
Mashup Score: 0Opinion | There Is No Leadership Without Risk - 2 month(s) ago
Those in positions of leadership fear they will say the wrong thing, or say what they believe to be the right thing in the wrong way.
Source: www.nytimes.comCategories: General Medicine News, Hem/OncsTweet-
https://t.co/gFFjimmzEH via @NYTOpinion
-
-
Mashup Score: 0Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factor - PubMed - 3 month(s) ago
Acute graft-versus-host disease (aGVHD) is a potentially fatal complication of allogeneic hematopoietic cell transplantation that fails to improve with intense immunosuppression in some patients. We hypothesized that urinary-derived human chorionic gonadotropin (uhCG) could help facilitate resolutio …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
https://t.co/6Yyt3EPFQf
-
-
Mashup Score: 0
Treatments that aid inflammation resolution, immune tolerance, and epithelial repair may improve outcomes beyond high-dose corticosteroids and other broad immunosuppressants for life-threatening acute graft-versus-host disease (aGVHD). We studied the …
Source: www.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
https://t.co/ZqjETRBldG
-
-
Mashup Score: 0
The same qualities that make placentas so valuable during pregnancy make them profoundly useful for healing burns and wounds, too. So why do we throw so many away?
Source: www.nytimes.comCategories: General Medicine News, Hem/OncsTweet-
Your gentle reminder that commercial hCG contains EGF and helps resolve GI #GVHD , too. https://t.co/VjwLyls6t7 via @NYTimes
-
-
Mashup Score: 18Transplant & Cellular Therapy Symposium 2024 - 3 month(s) ago
This event aims to increase participants’ knowledge and enhance clinical understanding of the best practices and evidence-based advances in the care of patients who are undergoing cell transplantations, through discussions around current developments, new indications and novel therapeutics. Participants will also learn about personalized approaches to managing toxicities and rare complications post-transplant.
Source: www.roswellpark.orgCategories: General Medicine News, Hem/OncsTweet-
Just some slow and responsible post-@RoswellPark rounds, pre-@BuffaloBills game #deadlifts. Who is joining us for our TCT + #BillsMafia CME event on November 2? 🏈👋 Deadline to register is 10/25! https://t.co/fJE64sMR4s https://t.co/SKtnnjVCdW
-
-
Mashup Score: 21Telemedicine in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T Cell Therapy - 4 month(s) ago
Patients with high-risk acute leukemias and lymphomas undergo stem cell transplantation or cellular therapies to achieve a cure. These are complex treatments that are typically offered by specialty medical centers. Patients are treated and monitored in …
Source: www.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
Time away from home is one of the most significant costs of HCT and CAR T. For some, the travel burden makes the procedure impossible. What are we doing to reduce the barriers? Great ideas in here, @arpitapgandhi! https://t.co/DBkabuirXP
-
-
Mashup Score: 6Unveiling amphiregulin: a blood-based biomarker for graft-versus-host disease risk assessment and monitoring - 5 month(s) ago
Open access journal of the Ferrata-Storti Foundation, a non-profit organization Open access journal of the Ferrata-Storti Foundation, a non-profit organization University of Michigan, Michigan Medicine, Blood and Marrow Transplantation Program; Ann Arbor, MI To create an adaptation, translation, or derivative of the original work, for commercial e-prints a nd printed articles further permission is required. For information contact: marketing@haematologica.org
Source: haematologica.orgCategories: General Medicine News, Hem/OncsTweet-
Unveiling amphiregulin: a blood-based biomarker for graft-versus-host disease risk assessment and monitoring | Haematologica https://t.co/dhkxZWjkbi
-
All of this. The benefits of telemedicine far outweigh the risks. 💻🥼 https://t.co/uaTPrPhCnG via @NYTOpinion